Search research articles
Contact Us
Filters
Showing results (671-680 of 692) with videos related to
Page
of 70
Sort By:
Nature Medicine
|
July 3, 2019
Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors
Paloma Cejas, Yotam Drier, Koen M A Dreijerink, et al.
Frontiers in Oncology
|
September 16, 2022
Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022
Jolien Robijns, Raj G Nair, Joy Lodewijckx, et al.
Biorxiv : the Preprint Server for Biology
|
December 3, 2025
The <i>9p21.3</i> Coronary Artery Disease Risk Locus Modulates Vascular Cell-State Transitions via Enhancer-Driven Regulation of <i>MTAP</i>
Timothy N Audam, Benjamin Schmandt, Yi Huang, et al.
Nature
|
April 8, 2021
Genome-wide enhancer maps link risk variants to disease genes
Joseph Nasser, Drew T Bergman, Charles P Fulco, et al.
Biorxiv : the Preprint Server for Biology
|
February 27, 2026
Integrated inference of cancer gene expression from cell-free plasma chromatin
Gunsagar S Gulati, Damien Vasseur, Rashad Nawfal, et al.
Nature Biotechnology
|
September 21, 2010
Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications
R Alan Harris, Ting Wang, Cristian Coarfa, et al.
Clinical Genitourinary Cancer
|
September 6, 2024
Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint Inhibitor
Dimitra Rafailia Bakaloudi, Rafee Talukder, Dimitrios Makrakis, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
An Expanded Registry of Candidate cis-Regulatory Elements for Studying Transcriptional Regulation
Jill E Moore, Henry E Pratt, Kaili Fan, et al.
Cancer Medicine
|
October 1, 2025
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study
Amanda Nizam, Charles B Nguyen, Jinju Li, et al.
Clinical Genitourinary Cancer
|
May 16, 2025
Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology Subtypes
Dimitra Rafailia Bakaloudi, Rafee Talukder, Thomas Enright, et al.
Page
of 70
Search research articles
Search
Showing results (671-680 of 692) with videos related to
Sort By:
Page
of 70
Nature Medicine
|
July 3, 2019
Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors
Paloma Cejas, Yotam Drier, Koen M A Dreijerink, et al.
Frontiers in Oncology
|
September 16, 2022
Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022
Jolien Robijns, Raj G Nair, Joy Lodewijckx, et al.
Biorxiv : the Preprint Server for Biology
|
December 3, 2025
The <i>9p21.3</i> Coronary Artery Disease Risk Locus Modulates Vascular Cell-State Transitions via Enhancer-Driven Regulation of <i>MTAP</i>
Timothy N Audam, Benjamin Schmandt, Yi Huang, et al.
Nature
|
April 8, 2021
Genome-wide enhancer maps link risk variants to disease genes
Joseph Nasser, Drew T Bergman, Charles P Fulco, et al.
Biorxiv : the Preprint Server for Biology
|
February 27, 2026
Integrated inference of cancer gene expression from cell-free plasma chromatin
Gunsagar S Gulati, Damien Vasseur, Rashad Nawfal, et al.
Nature Biotechnology
|
September 21, 2010
Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications
R Alan Harris, Ting Wang, Cristian Coarfa, et al.
Clinical Genitourinary Cancer
|
September 6, 2024
Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint Inhibitor
Dimitra Rafailia Bakaloudi, Rafee Talukder, Dimitrios Makrakis, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
An Expanded Registry of Candidate cis-Regulatory Elements for Studying Transcriptional Regulation
Jill E Moore, Henry E Pratt, Kaili Fan, et al.
Cancer Medicine
|
October 1, 2025
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study
Amanda Nizam, Charles B Nguyen, Jinju Li, et al.
Clinical Genitourinary Cancer
|
May 16, 2025
Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology Subtypes
Dimitra Rafailia Bakaloudi, Rafee Talukder, Thomas Enright, et al.
Page
of 70